Old National Bancorp’s Aerie Pharmaceuticals AERI Stock Holding History

Old National Bancorp’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-17,092	Closed	-$128K	–	724
2022 Q2	$128K	Sell	17,092 -3,218	-16%	-$22.7K	﹤0.01%	618
2022 Q1	$185K	Buy	20,310 +3,869	+24%	+$29.8K	0.01%	514
2021 Q4	$115K	Sell	16,441 -503	-3%	-$5.26K	﹤0.01%	511
2021 Q3	$193K	Buy	+16,944	New	+$248K	0.01%	513
2021 Q2	–	Sell	-17,385	Closed	-$311K	–	584
2021 Q1	$311K	Sell	17,385 -11,855	-41%	-$205K	0.01%	450
2020 Q4	$395K	Buy	29,240 +1,332	+5%	+$16.1K	0.02%	389
2020 Q3	$328K	Buy	27,908 +16,336	+141%	+$199K	0.02%	389
2020 Q2	$171K	Buy	+11,572	New	+$171K	0.01%	511

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Old National Bancorp's AERI Position: Q3 2022 in Review

Old National Bancorp sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 17,092 shares — an estimated $128K sold.

Old National Bancorp first reported a position in AERI in Q2 2020 and held it in 8 quarters. The position peaked at $395K in Q4 2020. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

Old National Bancorp reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Old National Bancorp sold 17,092 Aerie Pharmaceuticals shares in Q3 2022, an estimated $128K.
Old National Bancorp first reported a position in Aerie Pharmaceuticals in Q2 2020 and held it in 8 quarters.
Old National Bancorp's Aerie Pharmaceuticals position peaked at $395K in Q4 2020.
156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Old National Bancorp's 13F filing for Q3 2022, filed 8 Nov 2022.